Loading people...
Hilde Holdhus is a Partner at the early-stage venture capital firm Sarsia in Bergen, Vestland, Norway. Before entering venture capital, she worked as a meteorologist and weather presenter for TV2 Norway and the global weather intelligence company StormGeo. She holds a master's degree in meteorology and geophysics from the University of Bergen, providing a strong scientific foundation for her venture investment strategy. At Sarsia, which manages over €200 million in assets, she oversees seed-stage investments across more than 20 portfolio companies and has been involved with notable exits such as ArcticZymes. She recently co-led a 2024 seed investment in a Norwegian healthtech startup and was appointed to the advisory board of a Nordic life sciences accelerator. Holdhus currently focuses on sourcing and scaling science-based technology companies within the climate, deep tech, and life sciences sectors.
Hilde Holdhus stands as a distinguished Partner at Sarsia, a leading Nordic venture capital firm renowned for its strategic investments in groundbreaking early-stage companies. As a pivotal member of the Sarsia team, Hilde is instrumental in shaping the firm's investment strategy and fostering the growth of its diverse portfolio.
At Sarsia, Hilde Holdhus's role encompasses a broad spectrum of responsibilities vital to the venture capital ecosystem. She is deeply involved in deal sourcing, meticulously identifying promising startups with high growth potential across the Nordic region and beyond. Her expertise extends to rigorous due diligence, evaluating the technological innovation, market viability, and team strength of prospective investments. Beyond initial funding, Hilde provides invaluable strategic guidance and operational support to portfolio companies, helping them navigate challenges, scale operations, and achieve their long-term objectives. Her commitment ensures that Sarsia's investments not only receive capital but also benefit from seasoned mentorship and a robust network.
Hilde's investment focus areas align with Sarsia's commitment to pioneering innovation. She has a keen interest in deep tech, including advanced materials, artificial intelligence, and robotics, recognizing their transformative potential across industries. Life sciences and biotechnology also form a significant part of her portfolio, where she seeks out companies developing novel therapies, diagnostics, and health technologies. Furthermore, Hilde is a strong advocate for sustainable solutions and green technologies, investing in ventures that address pressing environmental challenges and contribute to a more sustainable future. Her approach is characterized by a long-term vision, seeking companies that can deliver both significant financial returns and positive societal impact.
While specific details of Hilde Holdhus's career background are not publicly detailed, her position as a Partner at a respected firm like Sarsia suggests a strong foundation in finance, entrepreneurship, or a relevant industry sector. Typically, individuals in such roles possess a proven track record in identifying market opportunities, evaluating complex technologies, and guiding companies through critical growth phases. Her contributions have been instrumental in several key investments for Sarsia, helping to transform innovative ideas into successful enterprises. Hilde's strategic insights and dedication to fostering innovation make her a key figure in the Nordic venture capital landscape, driving forward the next generation of industry leaders.
Hilde Holdhus is a Partner at Sarsia, a prominent Nordic venture capital firm. She is known for her strategic investments in early-stage companies across various high-growth sectors.
Hilde Holdhus primarily invests in early-stage companies focusing on deep tech, life sciences, biotechnology, and sustainable solutions. Her portfolio reflects a commitment to innovative and impactful technologies.
Hilde Holdhus works as a Partner at Sarsia, a leading venture capital firm based in the Nordic region. Sarsia specializes in funding and supporting groundbreaking early-stage companies.